SLDB logo

Solid Biosciences (SLDB) Company Overview

Profile

Full Name:

Solid Biosciences Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 26, 2018

Indexes:

Not included

Description:

Solid Biosciences is a biotechnology company focused on developing treatments for Duchenne muscular dystrophy (DMD), a rare genetic disease. They aim to create innovative therapies to improve the lives of patients and their families, using advanced science and technology to address unmet medical needs.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Mar 6, 2025

Recent annual earnings:

Mar 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 28, 2022

Analyst ratings

Recent major analysts updates

Mar 7, 25 Citizens Capital Markets
Market Outperform
Mar 7, 25 Chardan Capital
Buy
Feb 19, 25 Chardan Capital
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Truist Securities
Buy
Dec 13, 24 Wedbush
Outperform
Dec 12, 24 HC Wainwright& Co.
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 10, 24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Solid Biosciences?
  • Does Solid Biosciences pay dividends?
  • What sector is Solid Biosciences in?
  • What industry is Solid Biosciences in?
  • What country is Solid Biosciences based in?
  • When did Solid Biosciences go public?
  • Is Solid Biosciences in the S&P 500?
  • Is Solid Biosciences in the NASDAQ 100?
  • Is Solid Biosciences in the Dow Jones?
  • When was Solid Biosciences's last earnings report?
  • When does Solid Biosciences report earnings?
  • Should I buy Solid Biosciences stock now?

What is the ticker symbol for Solid Biosciences?

The ticker symbol for Solid Biosciences is NASDAQ:SLDB

Does Solid Biosciences pay dividends?

No, Solid Biosciences does not pay dividends

What sector is Solid Biosciences in?

Solid Biosciences is in the Healthcare sector

What industry is Solid Biosciences in?

Solid Biosciences is in the Biotechnology industry

What country is Solid Biosciences based in?

Solid Biosciences is headquartered in United States

When did Solid Biosciences go public?

Solid Biosciences's initial public offering (IPO) was on January 26, 2018

Is Solid Biosciences in the S&P 500?

No, Solid Biosciences is not included in the S&P 500 index

Is Solid Biosciences in the NASDAQ 100?

No, Solid Biosciences is not included in the NASDAQ 100 index

Is Solid Biosciences in the Dow Jones?

No, Solid Biosciences is not included in the Dow Jones index

When was Solid Biosciences's last earnings report?

Solid Biosciences's most recent earnings report was on Mar 6, 2025

When does Solid Biosciences report earnings?

The next expected earnings date for Solid Biosciences is May 15, 2025

Should I buy Solid Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions